Ironwood Investment Counsel’s Edwards Lifesciences EW Stock Holding History

Ironwood Investment Counsel’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$655K	Sell	8,183 -173	-2%	-$14.3K	0.09%	157
2025 Q4	$712K	Sell	8,356 -16	-0.2%	-$1.31K	0.1%	152
2025 Q3	$651K	Sell	8,372 -145	-2%	-$11.3K	0.09%	160
2025 Q2	$666K	Sell	8,517 -36	-0.4%	-$2.69K	0.1%	144
2025 Q1	$620K	Sell	8,553 -205	-2%	-$14.7K	0.11%	143
2024 Q4	$648K	Sell	8,758 -1,041	-11%	-$72.9K	0.11%	142
2024 Q3	$647K	Buy	9,799 +11	+0.1%	+$799	0.11%	148
2024 Q2	$904K	Sell	9,788 -359	-4%	-$31.8K	0.16%	123
2024 Q1	$970K	Sell	10,147 -427	-4%	-$35.9K	0.17%	118
2023 Q4	$806K	Sell	10,574 -100	-0.9%	-$6.96K	0.15%	129
2023 Q3	$739K	Buy	+10,674	New	+$858K	0.16%	127

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ironwood Investment Counsel's EW Position: Q1 2026 in Review

Ironwood Investment Counsel reduced its Edwards Lifesciences (EW) stake by 2.1% in Q1 2026, selling an estimated $14.3K and leaving 8,183 shares worth $655K. The position accounts for 0.09% of the portfolio, ranked #157.

Ironwood Investment Counsel first reported a position in EW in Q3 2023 and has held it in 11 quarters since. The position peaked at $970K in Q1 2024. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Ironwood Investment Counsel held 8,183 shares of Edwards Lifesciences worth $655K as of Q1 2026.
Ironwood Investment Counsel sold 173 Edwards Lifesciences shares in Q1 2026, an estimated $14.3K.
Edwards Lifesciences made up 0.09% of Ironwood Investment Counsel's portfolio in Q1 2026, its #157 holding.
Ironwood Investment Counsel first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 11 quarters since.
Ironwood Investment Counsel's Edwards Lifesciences position peaked at $970K in Q1 2024.
1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Ironwood Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.